1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells (1995)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - HU
- Unidades: FM; HU
- Assunto: RADIOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: Universidade do Chile
- Publisher place: Santiago
- Date published: 1995
- Source:
- Conference titles: Santiago Southern Summer Symposia
-
ABNT
BRENTANI, Maria Mitzi et al. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. 1995, Anais.. Santiago: Universidade do Chile, 1995. . Acesso em: 15 abr. 2026. -
APA
Brentani, M. M., Federico, M. H. H., Folgueira, M. A. A. K., & Escaleira, M. T. F. (1995). 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. In Molecular Biology of Cell Differentiation and Embryonic Development. Santiago: Universidade do Chile. -
NLM
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2026 abr. 15 ] -
Vancouver
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2026 abr. 15 ] - Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer
- Estudo da ploidia e indice proliferativo (fase s) por citometria de fluxo em carcinomas invasivos do colo uterino
- Transforming growth factor expression in head and neck cancer
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Thymocyte subpopulations and clonality in myasthenia gravis
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
